Empowering hospitals around the globe by providing free access to cutting-edge AI tools.

Since 2022, more than 6,000 women have had their exams passed through MIRAI and patients with increased breast cancer risk have been called for a differentiated screening program. Beyond the fact that these are important steps towards having a risk-based screening program implemented in Brazil's public health system, the opportunity for an early diagnosis is a life-changing factor for all these women! Dr. Grasiela Benini, MD
Head of Mastology & Mastology Residency Program Coordinator
Santa Marcelina Hospital

The integration of Mirai into our oncology department is a game-changer for breast cancer care in Upper Egypt. This advanced AI technology will enable us to predict and detect breast cancer much earlier than traditional methods, providing our patients with a better chance of successful treatment and recovery. Dr. Emad Shash
Head of Medical Oncology Department
Shefa Al Orman Hospital

For patients with breast cancer, learning about the pathology can help them regain control of their lives, especially when they are shown the hopeful data of healing and recovery. Dr. Luz Fernanda Sua Villegas, MD, PhD
Pathologist
Fundación Valle del Lili

In Chile, there are no cancer screening policies as defined by the WHO, only recommendations and for some types of cancers, financial coverage for the population. Therefore, there are tremendous opportunities regarding cancer prevention and early detection, especially for lower income people. Dr. Arnaldo Marín
PhD Faculty of Medicine, Department of Basic and Clinical Oncology
University of Chile